RB Global Other Income (Expense) decreased by 43.8% to -$2.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 428.6%, from $700.00K to -$2.30M.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20M | $602.00K | $300.00K | $800.00K | $1.10M | $2.40M | $200.00K | $400.00K | $1.70M | -$800.00K | -$200.00K | -$1.20M | $700.00K | $200.00K | -$1.60M | -$2.30M |
| QoQ Change | — | -49.7% | -50.2% | +166.7% | +37.5% | +118.2% | -91.7% | +100.0% | +325.0% | -147.1% | +75.0% | -500.0% | +158.3% | -71.4% | -900.0% | -43.8% |
| YoY Change | — | — | — | -33.1% | +82.7% | +700.0% | -75.0% | -63.6% | — | -133.3% | -200.0% | -400.0% | +187.5% | +200.0% | -33.3% | -428.6% |